Page last updated: 2024-10-30

mecamylamine and Nerve Degeneration

mecamylamine has been researched along with Nerve Degeneration in 1 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Nerve Degeneration: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.

Research Excerpts

ExcerptRelevanceReference
"Clinical studies have reported that the nicotinic receptor agonist varenicline improves balance and coordination in patients with several types of ataxia, but confirmation in an animal model has not been demonstrated."3.79Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia. ( Antilla, JC; Bickford, PC; Engberg, ME; Hudson, CE; Kang, CW; Lambert, CS; Philpot, RM; Rowell, PP; Wecker, L; Zesiewicz, TA, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wecker, L1
Engberg, ME1
Philpot, RM1
Lambert, CS1
Kang, CW1
Antilla, JC1
Bickford, PC1
Hudson, CE1
Zesiewicz, TA1
Rowell, PP1

Other Studies

1 other study available for mecamylamine and Nerve Degeneration

ArticleYear
Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia.
    Neuropharmacology, 2013, Volume: 73

    Topics: Animals; Ataxia; Benzazepines; Cerebellum; Dose-Response Relationship, Drug; Gait; Male; Mecamylamin

2013